We recently compiled a list of the 10 Firms Kick Off 2025 Trading in The Red. In this article, we are going to take a look at ...

We recently published a list of 10 Biggest Gainers of Last Week. In this article, we are going to take a look at where Teva ...

TEV-56278 is under clinical development by Teva Pharmaceutical Industries and currently in Phase I for Solid Tumor.

The US Court of Appeals for the Federal Circuit on Friday affirmed a lower district court order against Israeli ...

Eton Pharmaceuticals, Inc. recently announced the completion of its acquisition of Galzin® (zinc acetate) from Teva ...

In this article, we are going to take a look at where Teva Pharmaceuticals Industries Ltd. (NYSE:TEVA) stands against the other stocks. The stock market finished the first trading day of the year ...

Teva's vice president of U.S. innovative medicines, Heather DeMyers, explained in a recent interview with Fierce Pharma. Teva draws $100M from Royalty funding to bankroll long-acting schizophrenia ...

Technical analysis for Teva Pharmaceutical Industries Limited American Depositary Shares TEVA including support levels ...

Teva Pharmaceutical Industries continues to impress investors with strong sales growth and promising development. Click here ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...